Screener
Praxis Precision Medicines, Inc. PRAX Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $69.42M+10.2% | $77.99M+28.3% | $77.51M+37.7% | $65.8M+57.1% | $63.01M+131% | ||
| $27.49M+110% | $27.87M+100% | $19.54M+29.1% | $12.56M-17.7% | $13.06M+23.4% | ||
| $96.9M+27.4% | $105.86M+41.7% | $97.04M+35.9% | $78.36M+37.1% | $76.07M+101% | ||
| -$96.9M-27.4% | -$105.86M-41.7% | -$97.04M-51.7% | -$78.36M-37.9% | -$76.07M-103% | ||
| $13.18M+167% | $13.3M+145% | $8.13M+54.1% | $4.43M-10.2% | $4.94M+2.7% | ||
| -$83.72M-17.7% | -$92.56M-33.6% | -$88.91M-51.5% | -$73.93M-42.4% | -$71.13M-118% | ||
| -$2.87+13.3% | -$3.20+2.7% | -$3.51-17.0% | -$3.36-22.2% | -$3.31-90.2% | ||
| -$96.87M-27.4% | -$105.82M-41.7% | -$97.02M-51.8% | -$78.34M-38.1% | -$76.02M-103% | ||
| -$96.9M-27.4% | -$105.86M-41.7% | -$97.04M-51.7% | -$78.36M-37.9% | -$76.07M-103% |
FAQ
- Is Praxis Precision Medicines, Inc. profitable?
- Praxis Precision Medicines, Inc. is not currently profitable: it reported a net loss of $339.1M over the trailing twelve months, a -3658.5% net margin.
- What is Praxis Precision Medicines, Inc.'s earnings per share?
- Praxis Precision Medicines, Inc.'s diluted EPS over the trailing twelve months is $-12.94.
- Where does Praxis Precision Medicines, Inc.'s income statement data come from?
- Every line is extracted from Praxis Precision Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.